Sept 24 (Reuters) - Trinity Biotech PLC ( TRIB ):
* TRINITY BIOTECH ANNOUNCES ACQUISITION OF METABOLOMICS
DIAGNOSTICS TO GROW PRESENCE IN MATERNAL HEALTH MARKET
* TRINITY BIOTECH PLC ( TRIB ) - DEAL VALUES METABOLOMICS DIAGNOSTICS
AT
$1.3 MILLION
* TRINITY BIOTECH PLC ( TRIB ) - PREPSIA TEST TO BE COMMERCIALIZED IN
U.S.
IN 2025
* TRINITY BIOTECH PLC ( TRIB ) - FIRST REVENUES FROM PREECLAMPSIA
TESTING
EXPECTED IN 2025
Source text for Eikon:
Further company coverage: